Skip to content

Laryngeal Mask General Anesthesia with Remimazolam Combined with Remifentanil in Elderly Patients undergoing Minimally Invasive Urological Surgery: a randomized clinical trial.

A study of Laryngeal Mask General Anesthesia with Remimazolam Combined with Remifentanil in Elderly Patients undergoing Minimally Invasive Surgery of in Urology

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076793
Enrollment
Unknown
Registered
2023-10-18
Start date
2023-10-20
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Interventions

Propofol group:Propofol
Remi-High group:Remimazolam 6 mg/kg/h
Remi-Low group:Remimazolam 3mg/kg/h

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Patients who are over 60 years old, 2.ASA1-III grade 3. The surgical position is supine or lithotomy position 4. Undergo minimally invasive urological surgery for no less than 1 hour 5. Undergo laryngeal mask surgery under general anesthesia. 6. After surgery, they are planned to be sent to a recovery room for resuscitation.

Exclusion criteria

Exclusion criteria: 1. Surgery for controlled hypotension or pressor; 2. Patients with difficult airways; 3.Alcoholics and drug addiction; 4. Patients with delayed gastric retention or gastric emptying; 5.Individuals who are allergic to the studied medication; 6.Patients with end-stage renal failure; 7.Patients with severe hypertension (systolic blood pressure = 180mmHg, or diastolic blood pressure = 110mmHg); 8.Within 7 days, if bilirubin levels exceed 3.0mg/dl, or if aspartate transaminase or alanine transaminase levels increase by more than three times; 9. Patients who are unable to communicate; 10.Emergency surgery; 11.Acute narrow angle glaucoma, myasthenia gravis, shock or coma, acute alcoholism, or laboratory test abnormalities.

Design outcomes

Primary

MeasureTime frame
Efficacy;

Secondary

MeasureTime frame
Vital signs;characteristic of anaesthesia and surgery;

Countries

China

Contacts

Public ContactXuehai Guan

The First Affiliated Hospital of Guangxi Medical University

guan_xh@aliyun.com+86 185 8769 7310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026